Abdulkarim Najjar und Discovery - Info zur Person

(1 - 11 von 16

)

Discovery of novel dual inhibitors of receptor tyrosine kinases EGFR...

doaj.org

Novel 4-benzylamino benzo-anellated pyrrolo[2,3-b]pyridines have been synthesized with varied substitution patterns both at the molecular scaffold of the

Discovery of Novel Dual Inhibitors of Receptor Tyrosine Kinases EGFR...

books.google.de

Contributors, Cornelius Hempel, Frank Totzke, Christoph Schächtele, Abdulkarim Najjar, Wolfgang Sippl, Christoph Ritter, Andreas Hilgeroth. Publisher, Informa ...

A Multi-Objective Genetic Algorithm for Outlier RemovalACS Publications

pubs.acs.org

von OE Nahum · · Zitiert von: 8 — Abdulkarim Najjar, Fidele Ntie-Kang, Wolfgang Sippl. Application of Computer Modeling to Drug Discovery: Case Study of PRK1 Kinase ... von OE Nahum · · Zitiert von: 8 — Abdulkarim Najjar, Fidele Ntie-Kang, Wolfgang Sippl. Application of Computer Modeling to Drug Discovery: Case Study of PRK1 Kinase ...

Discovery of novel dual inhibitors of receptor tyrosine kinases EGFR...

www.sciencegate.app

Read Discovery of novel dual inhibitors of receptor tyrosine kinases EGFR and PDGFR-β related to anticancer drug resistance

Discovery of novel substituted benzo-anellated ScienceDirect.com

www.sciencedirect.com

von T Fischer · · Zitiert von: 18 — Tim Fischer a , Thomas Krüger a , Abdulkarim Najjar a , Frank Totzke b , Christoph Schächtele b , Wolfgang Sippl a , Christoph Ritter c , Andreas Hilgeroth a. von T Fischer · · Zitiert von: 18 — Tim Fischer a , Thomas Krüger a , Abdulkarim Najjar a , Frank Totzke b , Christoph Schächtele b , Wolfgang Sippl a , Christoph Ritter c , Andreas Hilgeroth a.

Discovery of novel dual inhibitors of receptor tyrosine ...Reaction Biology

www.reactionbiology.com

von T Fischer · · Zitiert von: 17 — To cite this article: Tim Fischer, Abdulkarim Najjar, Frank Totzke, Christoph Schächtele, Wolfgang. Sippl, Christoph Ritter & Andreas ... von T Fischer · · Zitiert von: 17 — To cite this article: Tim Fischer, Abdulkarim Najjar, Frank Totzke, Christoph Schächtele, Wolfgang. Sippl, Christoph Ritter & Andreas ...

Application of Computer Modeling to Drug Discovery: Case Study of

moam.info

Chapter from the book Unique Aspects of Anti-cancer Drug Development. Downloaded from: [1] Hanahan D. Rethinking ...

Application of Computer Modeling to Drug Discovery: Case Study of...

ouci.dntb.gov.ua

von A Najjar · Zitiert von: 1 — Journal: Unique Aspects of Anti-cancer Drug Development, Publisher: InTech. Authors: Abdulkarim Najjar, Fidele Ntie-Kang, Wolfgang Sippl ... › works

Discovery of dually acting small-molecule inhibitors of...

pubs.rsc.org

Cornelius Hempel a, Abdulkarim Najjar a, Frank Totzke b, Christoph Schächtele b, Wolfgang Sippl a, Christoph Ritter c and Andreas Hilgeroth * ...

Discovery of novel dual inhibitors of receptor tyrosine kinases EGFR...

pubmed.ncbi.nlm.nih.gov

With ongoing resistance problems against the marketed EGFR inhibitors having a quinazoline core scaffold there is a need for the development of novel...

Discovery of novel dual inhibitors of receptor tyrosine kinases EGFR...

www.ncbi.nlm.nih.gov

Tim Fischer,a Abdulkarim Najjar,a Frank Totzke,b Christoph Schächtele,b Wolfgang Sippl,a Christoph Ritter,c and Andreas Hilgerotha ...

Alle Infos zum Namen "Abdulkarim Najjar"

Verwandte Suchanfragen zu Abdulkarim Najjar

Andreas Hilgeroth
Frank Totzke
Matthias Schmidt

Frank Erdmann
Christoph Ritter
Wolfgang Sippl

Andreas Schepky
Jochen Kühnl
Anton Luft

Person "Najjar" (1)
Vorname "Abdulkarim" (38)
Name "Najjar" (201)

sortiert nach Relevanz / Datum

Erweiterte Suche

Person-Suchen: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Abdulkarim Najjar und Discovery Person-Info